NCT05864196View on ClinicalTrials.gov

Two Fraction Prostate SBRT With DIL SIB

PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Prostate Cancer
Interventions
RADIATION

Two-Fraction Stereotactic Body Radiation Therapy (SBRT)

Two-fraction SBRT with an MRI directed, dominant intraprostatic lesion, simultaneous integrated boost (SIB) based on genomic classification in the treatment of localized prostate cancer.

Trial Locations (2)

10016

RECRUITING

NYCyberKnife at Perlmutter Cancer Center, New York

11501

RECRUITING

NYU Langone Hospital - Long Island, Mineola

All Listed Sponsors
lead

NYU Langone Health

OTHER